Project Details
Description
EXTEND - Preserving Beta-Cell Function with Tocilizumab in New Onset Type 1 Diabetes
| Status | Finished |
|---|---|
| Effective start/end date | 9/1/14 → 1/31/22 |
Funding
- BENAROYA RESEARCH INST AT VIRGINIA MASON
- NIH NATIONAL INST OF ALLERGY & INFECT DI
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.